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Robo keeps axons moving
F
or migrating axons, attraction becomes 
repulsion with the fl  ip of an alternatively 
spliced switch, according to Zhe Chen, 
Marc Tessier-Lavigne (Genentech Inc., San 
Francisco, CA), and colleagues.
A melange of chemoattractants and repellants 
guides growing axons to their targets. Axons that 
cross the midline of the spinal cord on their way 
toward the nascent brain, however, have the 
complicated task of having to move past local 
attractants at the midline to complete their journey.
Midline cells also produce repulsive mole-
cules called Slits; but by keeping levels of the 
Slit receptors Robo1 and 2 low, axons approaching 
the midline can ignore Slits and instead respond 
only to attractants. As axons cross the midline, 
they up-regulate Robo1 and 2, become more 
sensitive to the repellants, and so are booted out 
the other side. Precrossing axons also express 
Robo3, which silences Robo1 and 2. But, curi-
ously, Robo3 is also found on postcrossing 
axons, when Robo-mediated repulsion is at its 
strongest. “That was a puzzle,” Tessier-Lavigne 
says. And it’s that puzzle they’ve resolved in 
the current study.
While sequencing a collection of Robo3 
cDNAs, the authors discovered two isoforms, one 
with and one without the two terminal exons. “We 
fell off our chairs when we did the immunohisto-
chemistry,” Tessier-Lavigne says. Robo3.1 was 
expressed on the precrossing axonal segment, 
whereas Robo3.2 was found on the postcrossing 
segment. Overexpression of 3.1 facilitated cross-
ing but led many axons to recross. Robo3.2 over-
expression prevented most axons from crossing 
all together, but those that did never recrossed.
The results suggest that unlike Robo3.1, 
Robo3.2 is not a silencer of the Slit receptors, 
but instead cooperates with them. “Our hypoth-
esis is that Robo3.1 and 3.2 are tied together to 
give you an all-or-nothing switch,” says Tessier-
Lavigne. The mechanisms controlling this 
switch are yet to be determined.
Chen, Z., et al. 2008. Neuron. 58:325–332.
Sweeter tumors with EGFR
E
GFR sweetens cancer cells to keep them alive, say Zhang Weihua, 
Mien-Chie Hung, Isaiah Fidler, and colleagues (University of Texas, 
Houston, TX).
Prognosis for many epithelial tumors correlates with the expression 
level of epidermal growth factor receptor. “It has traditionally been 
thought that tumor cells with too much 
receptor have too much tyrosine kinase 
activity,” Hung says. “But therapeutic 
kinase blockade has been only par-
tially successful.”
Investigating other mechanisms, 
the authors showed that knockdown 
of EGFR reduced intracellular glucose 
levels, and increased production of 
energy-scavenging autophagosomes, ultimately leading to cell death. 
This cell death could be prevented by providing extra glucose.
This effect on cellular glucose is due to an interaction between EGFR 
and the sodium/glucose cotransporter, SGLT1, the team found. EGFR 
knockdown reduced expression of SGLT1, and SGLT1 knockdown caused 
autophagosome-induced death. Transporter loss was not due to lowered 
transcription, suggesting that the protein became unstable in the absence 
of EGFR. EGFR’s stabilizing effect was dependent on its extracellular 
domain and remained even in the absence of its kinase activity.
“The excess stabilization of the glucose transporter allows these 
cells to survive in harsher conditions,” Hung says. Targeting this additional 
function of EGFR might therefore make for a better therapy.
Weihua, Z., et al. 2008. Cancer Cell. 13:385–393.
Abundance of ITAM 
prevents autoimmunity
F
or T cell receptors, more activation motifs means less autoimmunity, 
say Jeff Holst, Dario Vignali (St. Jude’s Children’s Research Hospital, 
Memphis, TN), and colleagues.
The T cell receptor’s four CD3 subunits contain a total of 10 tyrosine-based 
activation motifs (ITAMs). These motifs dock with tyrosine kinases inside the cell 
to promote signaling, but it’s unclear why the receptor needs so many ITAMs.
The authors generated mice that expressed mutant CD3 subunits with 
different numbers of ITAMs. Mice with seven or more ITAMs on their CD3 
subunits developed normally, but with six or fewer, mice were prone to 
autoimmune disease. “Number was more important than ‘fl  avor,’” Vignali 
says. Although fl  avor—the specifi  c ITAM type—also played some part, 
since two of the four strains with six ITAMs remained healthy.
Autoimmunity can be caused by loss of tolerance for self-antigens during 
development in the thymus. To test whether ITAM number affected self-
antigen recognition, the authors created male mice in which either wild-type 
or mutant CD3 subunits were combined with a T cell receptor specifi  c for a 
male antigen. Although wild-type mice deleted thymic T cells bearing the 
receptor, those with few functional ITAMs allowed the T cells to develop 
and enter the periphery, where they could provoke an autoimmune reaction. 
“Self-antigens have to be recognized in the thymus even when affi  nity and 
density is low,” Vignali says. The large number of ITAMs might therefore 
ensure the message isn’t lost.
Holst, J., et al. 2008. Nat. Immunol. doi:10.1038/ni.1611.
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Knockdown of EGFR reduced cellular 
glucose by destabilizing SGLT1.
Precrossing axons express Robo3.1 (arrow). 
On crossing the midline, an alternative splicing switch 
turns off Robo3.1 in favor of Robo3.2 (arrow head).